$0.74
0.044[6.32%]
Last update: 8:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
| Open0.696 | Close0.740 |
| Vol / Avg.13.726K / 21.570K | Mkt Cap28.084M |
| Day Range0.650 - 0.760 | 52 Wk Range0.372 - 1.000 |
AgeX Therapeutics Stock (AMEX:AGE), Key Statistics
AgeX Therapeutics Stock (AMEX: AGE) analysis, key statistics.
Valuation Measures
Enterprise Value
59.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
733.67
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-43.1%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.58
Tangible Book value per share
-0.6
Total Liabilities (Quarterly)
34.6M
Total Assets
12.3M
Total Liabilities
34.6M
Profitability
Net income Growth
- -
Gross Margin
44.44%
Net Margin
-29655.56%
EBIT Margin
-20966.67%
EBITDA Margin
-20611.11%
Operating Margin
-20955.56%
AgeX Therapeutics Stock (AMEX:AGE), Key Statistics
AgeX Therapeutics Stock (AMEX: AGE) analysis, key statistics.
Valuation Measures
Enterprise Value
59.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
733.67
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-43.1%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.58
Tangible Book value per share
-0.6
Total Liabilities (Quarterly)
34.6M
Total Assets
12.3M
Total Liabilities
34.6M
Profitability
Net income Growth
- -
Gross Margin
44.44%
Net Margin
-29655.56%
EBIT Margin
-20966.67%
EBITDA Margin
-20611.11%
Operating Margin
-20955.56%
AgeX Therapeutics Stock (AMEX:AGE), Key Statistics
AgeX Therapeutics Stock (AMEX: AGE) analysis, key statistics.
Valuation Measures
Enterprise Value
59.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
733.67
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-43.1%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.58
Tangible Book value per share
-0.6
Total Liabilities (Quarterly)
34.6M
Total Assets
12.3M
Total Liabilities
34.6M
Profitability
Net income Growth
- -
Gross Margin
44.44%
Net Margin
-29655.56%
EBIT Margin
-20966.67%
EBITDA Margin
-20611.11%
Operating Margin
-20955.56%
AgeX Therapeutics Stock (AMEX:AGE), Key Statistics
AgeX Therapeutics Stock (AMEX: AGE) analysis, key statistics.
Valuation Measures
Enterprise Value
59.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
733.67
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-43.1%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.58
Tangible Book value per share
-0.6
Total Liabilities (Quarterly)
34.6M
Total Assets
12.3M
Total Liabilities
34.6M
Profitability
Net income Growth
- -
Gross Margin
44.44%
Net Margin
-29655.56%
EBIT Margin
-20966.67%
EBITDA Margin
-20611.11%
Operating Margin
-20955.56%
AgeX Therapeutics Stock (AMEX:AGE), Key Statistics
AgeX Therapeutics Stock (AMEX: AGE) analysis, key statistics.
Valuation Measures
Enterprise Value
59.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
733.67
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-43.1%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.58
Tangible Book value per share
-0.6
Total Liabilities (Quarterly)
34.6M
Total Assets
12.3M
Total Liabilities
34.6M
Profitability
Net income Growth
- -
Gross Margin
44.44%
Net Margin
-29655.56%
EBIT Margin
-20966.67%
EBITDA Margin
-20611.11%
Operating Margin
-20955.56%
AgeX Therapeutics Stock (AMEX:AGE), Key Statistics
AgeX Therapeutics Stock (AMEX: AGE) analysis, key statistics.
Valuation Measures
Enterprise Value
59.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
733.67
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-43.1%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.58
Tangible Book value per share
-0.6
Total Liabilities (Quarterly)
34.6M
Total Assets
12.3M
Total Liabilities
34.6M
Profitability
Net income Growth
- -
Gross Margin
44.44%
Net Margin
-29655.56%
EBIT Margin
-20966.67%
EBITDA Margin
-20611.11%
Operating Margin
-20955.56%
AgeX Therapeutics Stock (AMEX:AGE), Key Statistics
AgeX Therapeutics Stock (AMEX: AGE) analysis, key statistics.
Valuation Measures
Enterprise Value
59.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
733.67
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-43.1%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.58
Tangible Book value per share
-0.6
Total Liabilities (Quarterly)
34.6M
Total Assets
12.3M
Total Liabilities
34.6M
Profitability
Net income Growth
- -
Gross Margin
44.44%
Net Margin
-29655.56%
EBIT Margin
-20966.67%
EBITDA Margin
-20611.11%
Operating Margin
-20955.56%
AgeX Therapeutics Stock (AMEX:AGE), Key Statistics
AgeX Therapeutics Stock (AMEX: AGE) analysis, key statistics.
Valuation Measures
Enterprise Value
59.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
733.67
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-43.1%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.58
Tangible Book value per share
-0.6
Total Liabilities (Quarterly)
34.6M
Total Assets
12.3M
Total Liabilities
34.6M
Profitability
Net income Growth
- -
Gross Margin
44.44%
Net Margin
-29655.56%
EBIT Margin
-20966.67%
EBITDA Margin
-20611.11%
Operating Margin
-20955.56%
AgeX Therapeutics Stock (AMEX:AGE), Key Statistics
AgeX Therapeutics Stock (AMEX: AGE) analysis, key statistics.
Valuation Measures
Enterprise Value
59.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
733.67
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-43.1%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.58
Tangible Book value per share
-0.6
Total Liabilities (Quarterly)
34.6M
Total Assets
12.3M
Total Liabilities
34.6M
Profitability
Net income Growth
- -
Gross Margin
44.44%
Net Margin
-29655.56%
EBIT Margin
-20966.67%
EBITDA Margin
-20611.11%
Operating Margin
-20955.56%